LONGEVITY OF RABIES ANTIBODY TITER IN RECIPIENTS OF HUMAN-DIPLOID CELL RABIES VACCINE

被引：38

作者：

BRIGGS, DJ ^{[1
]}

SCHWENKE, JR ^{[1
]}

机构：

[1] KANSAS STATE UNIV AGR & APPL SCI,DEPT STAT,MANHATTAN,KS 66506

来源：

VACCINE | 1992年 / 10卷 / 02期

关键词：

RABIES; VACCINE; INTRAMUSCULAR; INTRADERMAL; LONGEVITY;

D O I：

10.1016/0264-410X(92)90029-J

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Sera from individuals across the USA and Peace Corps Volunteers (PCV) were assayed for neutralizing antibody to human diploid cell rabies vaccine (HDCV). A pairwise comparison between intramuscular (i.m.) and intradermal (i.d.) administration, PCV and non-PCV, revealed statistically significant differences between i.m. and i.d. for PCV and non-PCV, and between PCV and non-PCV for i.d. and i.m. administration. Survival analysis and frequency tables employing chi(2) tests determined that the percentage probability of maintaining an adequate titre from 1.5-2.0 years after primary vaccination was 99% in non-PCV i.m., 93% in non-PCV i.d., 88% in PCV i.m., and 64% in PCV i.d.

引用

页码：125 / 129

页数：5

共 50 条

[31] Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML [J].

Madhusudana, Shampur N. ;

Sanjay, Thitamaranahalli V. ;

Mahendra, Bangalore J. ;

Sudarshan, Mysore K. ;

Narayana, Doddabele H. Ashwath ;

Giri, Anand ;

Muhamuda, Kader ;

Ravi, Vasanthapuram ;

Vakil, Hoshang B. ;

Malerczyk, Cladius .

HUMAN VACCINES, 2006, 2 (05) :200-204

[32] Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis [J].

Preiss, Scott ;

Chanthavanich, Pornthep ;

Chen, Lin H. ;

Marano, Cinzia ;

Buchy, Philippe ;

van Hoorn, Rosa ;

Noordegraaf, Marije Vonk ;

Mukherjee, Piyali .

EXPERT REVIEW OF VACCINES, 2018, 17 (06) :525-545

[33] A phase 2b, Randomized, double blinded comparison of the safety and efficacy of the monoclonal antibody mixture SYN023 and human rabies immune globulin in patients exposed to rabies [J].

Quiambao, Beatriz P. ;

Payumo, Ronald Allan ;

Roa, Camilo ;

Borja-Tabora, Charissa Fay ;

Montellano, May Emmeline ;

De Los Reyes, Mari Rose ;

Zoleta-De Jesus, Loreta ;

Capeding, Maria Rosario ;

Solimen, Domingo P. ;

Barez, Marie Yvette ;

Reid, Caroline ;

Chuang, Ariel ;

Tsao, Eric ;

McClain, J. Bruce .

VACCINE, 2024, 42 (22)

[34] Determining factors for human rabies in Morocco: genetic variability, vaccine quality, or inadequate management [J].

Bouchrit, N ;

Khyatti, M ;

Nourlil, J ;

Dardari, R ;

Ibrahimy, S ;

Tordo, N ;

Bourhy, H ;

Benslimane, A .

MEDECINE ET MALADIES INFECTIEUSES, 2002, 32 (09) :508-513

[35] Comparison of a Novel Human Rabies Monoclonal Antibody to Human Rabies Immunoglobulin for Postexposure Prophylaxis: A Phase 2/3, Randomized, Single-Blind, Noninferiority, Controlled Study [J].

Gogtay, Nithya J. ;

Munshi, Renuka ;

Narayana, D. H. Ashwath ;

Mahendra, B. J. ;

Kshirsagar, Vikas ;

Gunale, Bhagwat ;

Moore, Susan ;

Cheslock, Peter ;

Thaker, Saket ;

Deshpande, Siddharth ;

Karande, Sunil ;

Kumbhar, Dipti ;

Ravish, H. S. ;

Harish, B. R. ;

Pisal, Sambhaji S. ;

Dhere, Rajeev ;

Parulekar, Varsha ;

Blackwelder, William C. ;

Molrine, Deborah C. ;

Kulkarni, Prasad S. .

CLINICAL INFECTIOUS DISEASES, 2018, 66 (03) :387-395

[36] Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children [J].

Angsuwatcharakon, Piyada ;

Khomvilai, Sumana ;

Limsuwun, Kornvika ;

Ratananpinit, Natchaya ;

Khamchat, Apinya ;

Sanitnai, Teeranit ;

Tantawichien, Terapong .

EXPERT REVIEW OF VACCINES, 2018, 17 (02) :185-188

[37] Potency evaluation of rabies vaccine for human use: The impact of reducing the number of animals per dilution - Part 2 [J].

Machado, Nathalia S. ;

Moreira, Wildeberg C. ;

Freitas, Jessica F. de S. ;

de Almeida, Antonio Eugenio C. C. ;

de Moura, Wlamir Correa .

BIOLOGICALS, 2020, 66 :30-34

[38] Acute bilateral vestibulocochlear neuritis following cultured cell vaccine administration for rabies post-exposure prophylaxis [J].

Mesquita, Emersom Cicilini ;

Rouanet, Carolina ;

Lucas, Gilberto Luciano ;

de Lemos, Alberto dos Santos ;

Lima, Marco Antonio .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 364 :198-199

[39] Acute bilateral vestibulocochlear neuritis following cultured cell vaccine administration for rabies post-exposure prophylaxis [J].

Mesquita, Emersom Cicilini ;

Rouanet, Carolina ;

Lucas, Gilberto Luciano ;

de Lemos, Alberto dos Santos ;

Lima, Marco Antonio .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 359 (1-2) :84-85

[40] Safety of new indigenous human Rabies Monoclonal Antibody (RMAb) for Post Exposure Prophylaxis [J].

Shivalingaiah, Anwith Huluvadi ;

Shankaraiah, Ravish Haradanhalli ;

Hanumanthaiah, Ashwath Narayana Doddabele .

INDIAN JOURNAL OF COMMUNITY HEALTH, 2018, 30 (03) :196-201

← 1 2 3 4 5 →